Clincosm LogoSign in Get a demo

stage iiia breast cancer

Showing 1 - 25 of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +11 more
  • Mobile, Alabama
  • +1023 more
Dec 7, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,

Active, not recruiting
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • +7 more
  • Birmingham, Alabama
  • +499 more
Nov 15, 2022

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer Trial in United States (Telephone-Based Intervention,

Recruiting
  • Stage IA Breast Cancer
  • +7 more
  • Telephone-Based Intervention
  • +2 more
  • Goldsboro, North Carolina
  • +3 more
Oct 27, 2022

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +1 more
Sep 9, 2022

Cancer Survivor, Early-Stage Breast Carcinoma, Stage 0 Breast Cancer Trial in Los Angeles, Baltimore, Boston (Educational

Active, not recruiting
  • Cancer Survivor
  • +9 more
  • Educational Intervention
  • +3 more
  • Los Angeles, California
  • +2 more
Jul 18, 2022

Breast Adenocarcinoma, Estrogen Receptor Negative, HER2/Neu Negative Trial in Canada, United States (Carboplatin,

Recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Mobile, Alabama
  • +1295 more
May 2, 2022

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +6 more
  • Baltimore, Maryland
    University of Maryland Baltimore
Apr 29, 2022

Cognitive Side Effects of Cancer Therapy, Depression, Recurrent Breast Carcinoma Trial in Columbus (typhoid vaccine, Placebo)

Active, not recruiting
  • Cognitive Side Effects of Cancer Therapy
  • +7 more
  • typhoid vaccine
  • Placebo
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Apr 20, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Cancer Survivor, Estrogen Receptor-positive Breast Cancer, Stage IA Breast Cancer Trial in Duarte (exercise intervention,

Active, not recruiting
  • Cancer Survivor
  • +7 more
  • exercise intervention
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Obesity, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Duarte (Dietary Intervention, Educational Intervention,

Active, not recruiting
  • Obesity
  • +7 more
  • Dietary Intervention
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

Active, not recruiting
  • HER2-positive Breast Cancer
  • +9 more
  • pertuzumab
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)

Active, not recruiting
  • Solid Neoplasm
  • +16 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Cancer Survivor, Stage 0 Breast Cancer, Stage IA Breast Cancer Trial in Columbus (Educational Intervention, Exercise

Completed
  • Cancer Survivor
  • +8 more
  • Educational Intervention
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 23, 2022

HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle

Recruiting
  • HER2 Negative Breast Carcinoma
  • +6 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 18, 2022

Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • External beam radiation therapy
  • New Brunswick, New Jersey
  • +1 more
Jan 30, 2022

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Aurora (Omega-3 fatty acid, Celecoxib)

Active, not recruiting
  • Stage IA Breast Cancer
  • +6 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jan 14, 2022

Breast Cancer, Breast Tumors, HER2-positive Breast Cancer Trial in Worldwide (TX05 (trastuzumab), Herceptin®, Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • +4 more
  • TX05 (trastuzumab)
  • +4 more
  • Lesnoy, Minsk Region, Belarus
  • +145 more
Jan 7, 2022

HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

Active, not recruiting
  • HER2/Neu Negative
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
  • +1 more
Jan 11, 2022

Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston

Completed
Has Results
  • Benign Breast Neoplasm
  • +11 more
  • Docosahexaenoic Acid
  • Placebo
  • Boston, Massachusetts
  • +3 more
Dec 3, 2021

Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer Trial in Puerto Rico, United States (Preventive

Completed
  • Febrile Neutropenia
  • +27 more
  • Preventive Intervention
  • +2 more
  • Jonesboro, Arkansas
  • +159 more
Dec 22, 2021